ATLASVertex Pharmaceuticals (VRTX) earnings date: Nov 2, 2026
Vertex Pharmaceuticals (VRTX) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 2, 2026, after the close. Analysts expect EPS of $4.36.
Source: company filings and exchange data · Updated Nov 2, 2026
Vertex Pharmaceuticals reports on Nov 2, 2026. One email the day before, with ATLAS’s read on Vertex Pharmaceuticals. You can switch it off at any time.
Alert me before VRTX reportsFree to start. Creating an account takes under a minute.
VRTX earnings at a glance
| Next report (confirmed) | Mon, Nov 2, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $4.36 |
| Last report | Aug 3, 2026 · In line |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -0.4% |
| Average move around a report | ±1.4% (last 4) |
| Sector | Healthcare · Biotechnology |
Vertex Pharmaceuticals earnings history: last 4 reports
Vertex Pharmaceuticals last reported on Aug 3, 2026: EPS of $4.73 against an estimate of $4.75 (-0.4% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 3, 2026 | $4.75 | $4.73 | -0.4% | In line | +0.3% |
| Jul 16, 2026 | $1.10 | $1.17 | +6.4% | Beat | +1.8% |
| Jun 25, 2026 | -$0.14 | -$0.16 | -14.3% | Miss | +3.4% |
| May 6, 2026 | $2.55 | $2.72 | +6.7% | Beat | +0.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
ATLAS view on VRTX before the report
| Last price | $558.88 (+3.5%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 51% |
| Likely 1-month range (50%) | $532.24 – $589.41 |
| Normal 1-day range (±1σ) | ±1.7% |
| ATLAS fair value | $342.16 ($235.66 – $414.19) · price is 63% above |
These figures come from the same calibrated model and valuation as the Vertex Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get the full ATLAS analysis for VRTX
See the fair value, the probability range and the earnings history of Vertex Pharmaceuticals on its ATLAS page.
Vertex Pharmaceuticals (VRTX) stock analysisPlans from €3.99 a month.
Vertex Pharmaceuticals earnings: frequently asked questions
When does Vertex Pharmaceuticals (VRTX) report earnings?
Vertex Pharmaceuticals is scheduled to report on Monday, November 2, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for VRTX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $4.36 per share (USD). Estimates can change before the report.
How often does VRTX beat earnings estimates?
Of its last 4 reports with a recorded result, Vertex Pharmaceuticals beat the EPS estimate 2 times; the average surprise was -0.4%. Past results do not predict the next one.
How much does VRTX move around earnings?
Over its last 4 reports the stock moved an average of 1.4% (absolute, from the close before the report day to the close after it), and finished higher 4 of 4 times.
Did Vertex Pharmaceuticals beat earnings estimates last quarter?
Vertex Pharmaceuticals last reported on Aug 3, 2026: EPS of $4.73 against an estimate of $4.75 (-0.4% surprise), in line with the estimate.
How much does VRTX usually move in a day?
On a normal trading day the ATLAS model puts VRTX’s one-day range at about ±1.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 2, 2026
Educational information, not investment advice. Disclaimer